Bataluna, Robert L.

HRN: 28-85-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
04/11/2026
04/18/2026
IV
600mg
Q8h
Fracture Open Complete Proximal Phalange 1st Digit Right Foot
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: